Merck keeps striking out on expanding its cancer-drug juggernaut

The company needs combinations to extend Keytruda sales after patent expires.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...